These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 8006339)

  • 61. Long-term treatment with bromocriptine of a plurihormonal pituitary adenoma secreting thyrotropin, growth hormone and prolactin.
    Shimatsu A; Murabe H; Nakamura Y; Mizuta H; Ihara C; Nakao K
    Endocr J; 1999 Feb; 46(1):159-65. PubMed ID: 10426581
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Human pituitary null cell adenomas and oncocytomas in vitro: effects of adenohypophysiotropic hormones and gonadal steroids on hormone secretion and tumor cell morphology.
    Asa SL; Cheng Z; Ramyar L; Singer W; Kovacs K; Smyth HS; Muller P
    J Clin Endocrinol Metab; 1992 May; 74(5):1128-34. PubMed ID: 1569159
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Changes in circulating levels of LH, FSH, LHbeta- and alpha-subunit after gonadotropin-releasing hormone, and of TSH, LHbeta- and alpha-subunit after thyrotropin-releasing hormone.
    Hagen C; McNeilly AS
    J Clin Endocrinol Metab; 1975 Sep; 41(3):466-70. PubMed ID: 808557
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function.
    Warfield A; Finkel DM; Schatz NJ; Savino PJ; Snyder PJ
    Ann Intern Med; 1984 Dec; 101(6):783-5. PubMed ID: 6497193
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
    Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
    J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vitro short-term effects of SMS 201-995, bromocriptine and TRH on growth hormone cell morphology from human pituitary adenomas.
    García García J; Jiménez Reina L; García Luna PP; Leal Cerro A; Astorga Jiménez R; García García-Revillo J; Bernal Valls G
    Histol Histopathol; 1989 Apr; 4(2):223-33. PubMed ID: 2520459
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Primary hyperprolactinemic amenorrhea. Report of 4 patients].
    Rudolf K; Smid I; Kunkel S; Bazsa-Kassai Z
    Zentralbl Gynakol; 1985; 107(14):894-8. PubMed ID: 3929499
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery.
    Harris RI; Schatz NJ; Gennarelli T; Savino PJ; Cobbs WH; Snyder PJ
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1288-93. PubMed ID: 6404924
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Follicle stimulating hormone-secreting pituitary adenoma: inappropriate secretion and effect of pulsatile luteinizing hormone releasing hormone analogue (buserelin) administration.
    Damjanović S; Micić D; Popović V; Petakov M; Kendereski A; Sumarac M; Manojlović D; Mićić J
    J Endocrinol Invest; 1991 Apr; 14(4):299-304. PubMed ID: 1713932
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Follicle-stimulating hormone-secreting pituitary adenomas.
    Beckers A; Stevenaert A; Mashiter K; Hennen G
    J Clin Endocrinol Metab; 1985 Sep; 61(3):525-8. PubMed ID: 2991325
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Diagnosis and treatment of pituitary adenomas.
    Chanson P; Salenave S
    Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Immunohistochemical and clinicoendocrinological studies of gonadotropin producing pituitary adenomas].
    Sanno N; Teramoto A; Inada K; Osamura Y
    No To Shinkei; 1992 Aug; 44(8):745-53. PubMed ID: 1419353
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Correlation between integrated LH and FSH levels and the response to luteinizing hormone relasing factor (LRF).
    Mortimer RH; Fleischer N; Lev-Gur M; Freeman RG
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1240-9. PubMed ID: 794076
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effect of TRH on beta-gonadotropin subunits in patients with pituitary microincidentalomas.
    Greenman Y; Trostanetsky Y; Sömjen D; Tordjman K; Kohen F; Stern N
    Eur J Endocrinol; 1999 Jul; 141(1):17-21. PubMed ID: 10407217
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.
    Hirasawa R; Hashimoto K; Makino S; Suemaru S; Takao T; Ota Z; Hoshida Y; Yoshino T; Akagi T
    Acta Med Okayama; 1991 Apr; 45(2):107-15. PubMed ID: 1867112
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Gonadotrophin and free alpha-subunit secretion in patients with acromegaly and clinically non-functioning pituitary tumors: anterior pituitary function and the effect of thyrotrophin-releasing hormone.
    Damjanović SS; Popović VP; Petakov MS; Nikolic-Durović MM; Doknić MZ; Gligorović MS
    J Endocrinol Invest; 1996 Nov; 19(10):663-9. PubMed ID: 9007697
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of increasing the frequency of low doses of gonadotropin-releasing hormone (GnRH) on gonadotropin secretion in GnRH-deficient men.
    Spratt DI; Finkelstein JS; Butler JP; Badger TM; Crowley WF
    J Clin Endocrinol Metab; 1987 Jun; 64(6):1179-86. PubMed ID: 3106396
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P; Arlot S; Bauters C; Chanson P; Kuhn JM; Pugeat M; Marechaud R; Teutsch C; Vidal E; Sassano P
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [TBL] [Abstract][Full Text] [Related]  

  • 79. alpha-Subunit and gonadotropin responses to luteinizing hormone-releasing hormone in hyperprolactinemic women before and after bromocriptine.
    Klibanski A; Beitins IZ; Zervas NT; McArthur JW; Ridgway EC
    J Clin Endocrinol Metab; 1983 Apr; 56(4):774-80. PubMed ID: 6187760
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The significance of alpha-subunit as a tumor marker for gonadotropin-producing pituitary adenomas.
    Demura R; Jibiki K; Kubo O; Odagiri E; Demura H; Kitamura K; Shizume K
    J Clin Endocrinol Metab; 1986 Sep; 63(3):564-9. PubMed ID: 2426298
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.